Limosilactobacillus reuteri Strains as Adjuvants in the Management of Helicobacter pylori Infection.
- 2021-07-20
- Review
- Medicina (Kaunas, Lithuania) 57(7)
- Costantino Dargenio
- Vanessa Nadia Dargenio
- Francesca Bizzoco
- Flavia Indrio
- Ruggiero Francavilla
- Fernanda Cristofori
- PubMed: 34357014
- DOI: 10.3390/medicina57070733
- Low evidence
As an adjuvant of standard regimens with antibiotics and pump inhibitors, L. reuteri can be used not only to improve cure rates, but especially to decrease gastrointestinal symptoms
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes